Alpha Tau Medical Ltd.

As of June 11, 2025, the market trend has shifted to bullish, supported by strong indicators like a bullish weekly MACD, confirming daily moving averages, and positive price action with today's high at 3.04, above the previous close of 2.90.

Alpha Tau Medical Ltd. is a micro-cap company in the Pharmaceuticals & Biotechnology industry, currently reporting a net profit loss of $9 million and a market cap of $250.71 million. Key financial metrics include a negative P/E ratio, a 0.00% dividend yield, and a return on equity of -57.63%.

As of Jun 18, Alpha Tau Medical Ltd. has a market capitalization of 250.71 million and reported net sales of 0.00 million with a net profit of -32.46 million over the last four quarters. The balance sheet shows shareholder's funds of 62.67 million and total assets of 86.20 million.